Detalles de la búsqueda
1.
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Blood
; 133(14): 1548-1559, 2019 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30658992
2.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med
; 377(5): 454-464, 2017 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28644114
3.
Application of multi-state models in cancer clinical trials.
Clin Trials
; 15(5): 489-498, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30035644
4.
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study.
Br J Haematol
; 171(3): 373-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26202857
5.
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).
Invest New Drugs
; 31(5): 1311-20, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23700288
6.
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Leukemia
; 35(9): 2539-2551, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33654204
7.
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Blood
; 112(5): 1646-54, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18502832
8.
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).
J Geriatr Oncol
; 11(1): 107-113, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31668825
9.
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.
Prostate Cancer Prostatic Dis
; 22(2): 309-316, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30385835
10.
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
Int J Radiat Oncol Biol Phys
; 71(1): 9-15, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18037582
11.
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.
BJU Int
; 101(1): 20-5, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17922873
12.
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.
Eur J Cancer
; 94: 115-125, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550566
13.
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.
J Clin Oncol
; 35(6): 591-597, 2017 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28199818
14.
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001.
Blood Adv
; 1(5): 331-340, 2017 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29034366
15.
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
Clin Genitourin Cancer
; 4(4): 269-74, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16729910
16.
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
Clin Cancer Res
; 11(5): 1815-20, 2005 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15756004
17.
Precautionary measures. Specialists discuss functional ergonomics and healing the injured worker.
Rehab Manag
; 22(9): 26-7, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20329664
18.
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
J Clin Oncol
; 32(11): 1143-50, 2014 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24590644
19.
Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125].
Eur J Cancer
; 103: 287, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30270112
20.
High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.
Leuk Res
; 35(3): 329-33, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20688393